Latest content
- Eli Lilly and InnoCare Pharma agree on $3.3bn drug research deal
- From activity to accountability: the omnichannel metrics that pharma leadership actually acts on
- AstraZeneca’s Trixeo gets EU approval for asthma maintenance treatment
- Engitix appoints Sonia Quaratino as EVP Chief Medical Officer
- CSL Seqirus announces strengthened vaccine partnership with UK government
Latest intelligence
- Cell and gene therapies – moving from niche innovations towards broader clinical use
- Creating a strong patent portfolio through constant communication
- Leading through complexity
- The Amazon reckoning: GLP-1s and the consumer lifestyle shift – why the molecule is no longer enough
- Lupus – moving patient care beyond current therapies towards resetting the immune system